RSS   Newsletter   Contact   Advertise with us

Protalix BioTherapeutic appoints David Granot to board

Staff Writer | Carmiel, Israel | August 14, 2018
David GranotProtalix BioTherapeutics, a biopharmaceutical company, announced that it has appointed David Granot to serve on the company’s board of directors.
In addition to Mr. Granot’s appointment as an independent director, he was also appointed to serve on the Company’s Audit Committee.

Mr. Granot currently serves on the Board of Directors of Ormat Technologies.

He also serves on the board of directors of Bezeq Israeli Telecommunication since May 22, 2012, where he served as temporary Acting Chairman, July 2017 through May 2018; Alrov Properties & Lodgings; and Jerusalem Economy.

Mr. Granot also serves on the board of directors of other privately-held companies.

Until March 2013, he was a director of Harel Insurance Investments and Financial Ltd. and Chairman of the Nostro investment committee of Harel Insurance.

From 2001 through 2007, he served as the Chief Executive Officer of the First International Bank of Israel Ltd, from 1998 through 2000 he served as the Chief Executive Officer of the Israel Discount Bank and from 1995 through 1998, he served as the Chief Executive Officer of the Israel Union Bank.

Mr. Granot holds a B.A. in Economics and an MBA, both from the Hebrew University of Jerusalem.


 LATEST MOVES FROM Israel 


MORE INSIDE POST